Literature DB >> 28342649

The prognosis of dementia with Lewy bodies.

Christoph Mueller1, Clive Ballard2, Anne Corbett2, Dag Aarsland3.   

Abstract

Dementia with Lewy bodies is the second most common form of neurodegenerative dementia, yet scarce evidence is available about its prognosis and natural history, which are crucial to inform clinical practice and research. Patients with dementia with Lewy bodies might have a less favourable prognosis, with accelerated cognitive decline, shorter lifespan, and increased admission to residential care than patients with Alzheimer's disease. Health-care costs and, importantly, caregiver burden, are also reported to be higher in dementia with Lewy bodies than in Alzheimer's disease. It is probable that causative factors for this less favourable prognosis are the increased prevalence and early emergence of neuropsychiatric symptoms in patients with dementia with Lewy bodies, and the challenge of accurate diagnosis. Evidence concerning quality of life and hospital admission rates is limited, despite their clinical and economic relevance.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28342649     DOI: 10.1016/S1474-4422(17)30074-1

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  55 in total

Review 1.  Clinical drug development for dementia with Lewy bodies: past and present.

Authors:  Garam Lee; Jeffrey Cummings; Boris Decourt; James B Leverenz; Marwan N Sabbagh
Journal:  Expert Opin Investig Drugs       Date:  2019-10-28       Impact factor: 6.206

2.  Vulnerability of multiple large-scale brain networks in dementia with Lewy bodies.

Authors:  Arianna Sala; Silvia Paola Caminiti; Leonardo Iaccarino; Luca Beretta; Sandro Iannaccone; Giuseppe Magnani; Alessandro Padovani; Luigi Ferini-Strambi; Daniela Perani
Journal:  Hum Brain Mapp       Date:  2019-07-19       Impact factor: 5.038

Review 3.  Assessment and Management of Neuropsychiatric Symptoms in Parkinson's Disease.

Authors:  Christoph Mueller; Anto P Rajkumar; Yi Min Wan; Latha Velayudhan; Dominic Ffytche; Kallol Ray Chaudhuri; Dag Aarsland
Journal:  CNS Drugs       Date:  2018-07       Impact factor: 5.749

Review 4.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

Review 5.  Defective Lysosomal Lipid Catabolism as a Common Pathogenic Mechanism for Dementia.

Authors:  Jun Yup Lee; Oana C Marian; Anthony S Don
Journal:  Neuromolecular Med       Date:  2021-02-07       Impact factor: 3.843

6.  Aβ exacerbates α-synuclein-induced neurotoxicity through impaired insulin signaling in α-synuclein-overexpressed human SK-N-MC neuronal cells.

Authors:  Ching-Chi Chang; Hsin-Hua Li; Yen-Ting Chang; Ying-Jui Ho; Ling-Jia Hsieh; Pai-Yi Chiu; Yu-Shih Cheng; Chih-Li Lin; Te-Jen Lai
Journal:  CNS Neurosci Ther       Date:  2017-11-01       Impact factor: 5.243

Review 7.  New Therapeutic Strategies for Lewy Body Dementias.

Authors:  Latha Velayudhan; Dominic Ffytche; Clive Ballard; Dag Aarsland
Journal:  Curr Neurol Neurosci Rep       Date:  2017-09       Impact factor: 5.081

8.  Associations among Braak stage, Parkinsonian gait, cognition, and functional status in autopsy-confirmed dementia with Lewy bodies.

Authors:  Ann M Mayo; Guerry M Peavy
Journal:  Int J Geriatr Psychiatry       Date:  2019-03-15       Impact factor: 3.485

Review 9.  Alzheimer's Disease-Related Dementias Summit 2016: National research priorities.

Authors:  Roderick A Corriveau; Walter J Koroshetz; Jordan T Gladman; Sophia Jeon; Debra Babcock; David A Bennett; S Thomas Carmichael; Susan L-J Dickinson; Dennis W Dickson; Marian Emr; Howard Fillit; Steven M Greenberg; Michael L Hutton; David S Knopman; Jennifer J Manly; Karen S Marder; Claudia S Moy; Creighton H Phelps; Paul A Scott; William W Seeley; Beth-Anne Sieber; Nina B Silverberg; Margaret L Sutherland; Angela Taylor; Christine L Torborg; Salina P Waddy; Amelie K Gubitz; David M Holtzman
Journal:  Neurology       Date:  2017-11-08       Impact factor: 9.910

10.  Evaluation of START (STrAtegies for RelaTives) adapted for carers of people with Lewy body dementia.

Authors:  Jennifer A Foley; Charlotte Dore; Angeliki Zarkali; Gill Livingston; Lisa Cipolotti; Catherine J Mummery; Rimona S Weil
Journal:  Future Healthc J       Date:  2020-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.